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Platform Abstracts / 54 (2014) S1eS16 S9Purpose: Two independent studies of rural African American
youths were used to test the moderation effect a novel haplotype
in the corticotropin-releasing hormone receptor 1 gene (CRHR1)
on the link between life stress and the change of depression over 4
years.
Methods: 16-year-old (N¼ 502) and 18-year-old (N¼ 347) African
American youths were randomly selected from rural Georgia as a
part of two 4-year longitudinal studies (SAAFT and AIM). Negative
life event and depression symptoms were collected over 4 years.
Genetic data were also collected along with the survey data.
Haplotype analysis were performed on 10 SNPs of the CRHR1 gene
and a GC haplotype was identiﬁed as a protective factor of youth
depression. A latent growth model was performed to test whether
the GC haplotype moderates the link between wave 1 negative life
event and change (slope) of youth depression across 4 years. We
replicated the analysis with the two independent data sets. All the
analyses were performed in MPLUS 6.0.
Results: A CRHR1 haplotype X negative life event (GXE) interaction
signiﬁcantly predicted the slope of youth depression in the latent
growth model (b ¼ -.03, p < .05 for SAAFT and b ¼ -.05, p < .05 for
AIM) With exposure to high level negative life event at wave 1
(1 SD above mean), youths who do not carry a CG copy in the
CRHR1 haplotype showed stable and high depression across time
while those who carry a least one CG copy showed a decreasing
trend in depression. Youths who carry a CG haplotype were pro-
tected from the inﬂuence of stressful life events. Similar results
were found both in SAAFT and AIM.
Conclusions: The replication design strengthens the ﬁndings of
the current study. Results suggest that a diathesis-stress hypoth-
esis was supported as oppose to a susceptibility hypothesis when
concerning a GXE interaction.
Sources of Support: This study was supported by Awards
Numbers R01DA021736 and P30DA027827 from the National
Institute on Drug Abuse.17.
EATING DISORDERS IN ADOLESCENTS: HOW DOES THE DSM-5
CHANGE THE DIAGNOSIS?
MartinM. Fisher, MD, FSAHM,Marisol Gonzalez, MD, JoanMalizio, RN.
Cohen Children’s Medical Center of New York.
Purpose: The 5th edition of the Diagnostic and Statistical Manual
(DSM-5) was published in May 2013. Several new eating disorder
diagnoses were included, with one goal of the changes being to
better classify the large number of patients who had received the
non-speciﬁc diagnosis of eating disorder not otherwise speciﬁed
(EDNOS) in the DSM-IV. This study evaluated the changes in
diagnosis for the patients presenting to one adolescent medicine
eating disorders program using the old DSM-IV and new DSM-5
criteria.
Methods: The 309 patients who presented from September 2011
through December 2012 for the evaluation of an eating disorder to
the out-patient ofﬁce of the Division of Adolescent Medicine of
Cohen Children’s Medical Center of New York were given both
DSM-IV and DSM-5 diagnoses by the lead author within 48 hours
of presentation. An algorithm provided by the Eating Disorders
Workgroup of the American Psychiatric Association was utilized to
make the DSM-5 diagnoses.
Results: DSM-IV diagnoses were: anorexia nervosa (AN)-81
(26.2%); bulimia nervosa (BN)-29 (9.6%); binge eating disorder(BED)-1 (0.3%); and EDNOS-198 (64%). All patients with AN, BN,
and BED in the DSM-IV had the same diagnosis in the DSM-5.
Among the 198 patients with EDNOS in the DSM-IV, 19 were re-
classiﬁed as AN, none were re-classiﬁed as BN or BED, a large
number were re-classiﬁed into the newly described Other Speci-
ﬁed Feeding or Eating Disorders (93 Atypical AN, 18 purging
disorder, 2 BN of low frequency, 2 BED of low frequency), 60 were
re-classiﬁed as the newly described diagnosis of Avoidant/
Restrictive Food Intake Disorder (ARFID), which includes those
who do not have fear of weight gain or distorted body image, and
only 4 were classiﬁed as Unspeciﬁed Feeding or Eating Disorder.
Conclusions: In this cohort of 309 patients with eating disorders,
more than 60% of patients were classiﬁed as having EDNOS using
the DSM-IV criteria and almost all of these patients were suc-
cessfully re-classiﬁed with a speciﬁc diagnosis using the DSM-5
criteria. Almost 20% of the patients were classiﬁed as having the
newly described diagnosis of ARFID in the DSM-5. These ﬁndings
demonstrate great promise for the use of the DSM-5 eating dis-
orders diagnoses in the years ahead.
Sources of Support: There are no sources of support.
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DEVELOPING A SEXUAL AND REPRODUCTIVE HEALTHCARE
GUIDE: THE VOICES OF YOUNG URBAN MINORITY MALES
AGED 15-24
Nanlesta Pilgrim, PhD 1, Jennifer Sherwood, BS 1,
Patricia J. Dittus, PhD 2, Penny Loosier, PhD 2, Jacky Jennings, PhD 1,
Kathleen R. Page, MD 3, Renata Arrington-Sanders, MD, MPH 3,
Freya L. Sonenstein, PhD 1, Arik V. Marcell, MD, MPH 2.
1Johns Hopkins Bloomberg School of Public Health; 2Centers for
Disease Control and Prevention; 3Johns Hopkins University.
Purpose: Clinic guides to successfully engage young males aged
15-24 in sexual and reproductive healthcare are lacking. This
study’s goal was to explore factors inﬂuencing young males’ use of
sexual and reproductive healthcare to inform such a guide.
Methods: 49 males were recruited to participate in focus groups
from communities with high sexually transmitted disease (STD)
rates in a northeastern city. Groups were stratiﬁed by age (4 among
15-19 yrs; 5 among 20-24 yrs), race/ethnicity (7 African American;
2 Latino) and sexual behavior (7 heterosexual; 2 non-heterosexu-
al). Trained male moderators were matched to participants’ race/
ethnicity and groups were conducted in English and Spanish,
depending on need. Participants were queried on factors inﬂu-
encing young males’ use of sexual/reproductive healthcare using a
brief self-administered survey and via a focus group moderator
guide. Groups lasted 60 minutes, and were audio-taped and tran-
scribed. Two researchers coded transcripts, categorized codes and
conducted content analyses. A third researcher corroborated
ﬁndings. Brief survey descriptive statistics were conducted. This
study was IRB approved.
Results: 90% of participants reported sexual behavior. In the last
year, 25% reported no regular doctor or insurance, 40% no STD/HIV
test, and 30% no STD/HIV counseling by a doctor. Content analyses
identiﬁed 5 domains inﬂuencing young males’ use of sexual/
reproductive healthcare: accessibility, clinic visibility, conﬁdenti-
ality, patient-centered care and interpersonal factors. Identiﬁed
themes within each domain serving as barriers and/or facilitators
of care included: 1) accessibility - (a) availability of affordable/free
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2) clinic visibility - (a) help to locate and receive services including
clinic marketing via traditional (e.g., TV) or new technology (e.g.,
phone apps); 3) conﬁdentiality - (a) fear providers do not maintain
conﬁdentiality and (b) applauding doctors who assure conﬁden-
tiality; 4) patient-centered care - (a) preference for female pro-
viders and (b) wanting to choose one’s own clinician; and 5)
interpersonal factors - (a) fears of positive STD test results and (b)
stigma associated with being tested for STDs. Themes did not vary
by participants’ sexual behavior. Language barriers at clinics were
discussed among Latino groups (e.g., needing translators and ma-
terials in Spanish).
In exploring source of sexual/reproductive healthcare, the
majority of participants reported mothers (84%) and doctors (81%)
as most helpful sources. Although 44% of participants reported the
Internet as an information source, participants discussed having
mixed feelings trusting this source and concerns about search
history privacy. Few participants reported having searched for a
clinic to go to for a personal concern on a home computer (43%) or
mobile device (23%) despite access to such devices.
Conclusions: Participants discussed speciﬁc factors inﬂuenced
their sexual and reproductive healthcare use that can be easily
incorporated into a clinic guide to assist in linking them to care
(e.g., clinic access information, conﬁdentiality assurances, patient-
centered care). Future work should evaluate whether a tailored
guide for young males results in their increased care use and
explore ways to address the continued fear and stigma of a HIV/
STD diagnosis.
Sources of Support: CDC 1H25PS003796 and the Secretary’s Mi-
nority AIDS Initiative.
19.
RESULTS FROM EKISS (ELECTRONIC KIOSK INTERVENTION FOR
SAFER-SEX): A PILOT RANDOMIZED CONTROLLED TRIAL TO
TEST AN INTERACTIVE COMPUTER-BASED INTERVENTION FOR
SEXUAL HEALTH IN ADOLESCENTS AND YOUNG ADULTS
Taraneh Shaﬁi, MD, MPH, Samantha K. Benson, MPH,
Diane M. Morrison, PhD, James P. Hughes, PhD,
Matthew R. Golden, MD, MPH, King K. Holmes, MD, PhD.
University of Washington.
Purpose: Sexually transmitted infections (STIs) and unintended
pregnancy rates are disproportionately high in adolescent and
young adult populations. We need effective, scalable strategies to
promote sexual health and prevent STIs and unintended preg-
nancies that reach young people in real-world settings. Interactive
computer-based interventions (ICBI) are promising tools to meet
these goals. The purpose of this study was to test the feasibility and
acceptability of an interactive computer-based intervention for
sexual health; assess the effectiveness of the intervention in
reducing unprotected sex; and pilot test biomarker outcomes of
STIs and unintended pregnancy.
Methods: The study is a pilot randomized controlled trial of males
and females (14-24 years) seeking care in a public health STD Clinic
and reporting at least one episode of unprotected vaginal sex in the
last 2 months. Randomization was computer generated and
stratiﬁed by gender, age group, and visit type. Investigators and
participants were blinded to allocation to Intervention or Control
Group. Participants entered their sexual history via Computer
Assisted Self-Interview and provided urine samples for Chlamydia,
gonorrhea and pregnancy (females) testing. The Interventiongroup completed an interactive-computer program and received
personal feedback from a Physician Avatar about their protective
and risky sexual behaviors; were offered video modules targeting
sexual health knowledge and skills; and identiﬁed a goal behavior
to change. At 3-month follow-up participants reported their
interim sexual history, underwent follow-up urine testing. The
primary outcome was unprotected vaginal sex (without condoms)
in the last 2 months. Secondary outcomes included unprotected
vaginal sex (without other contraception), number of sexual
partners, incident STIs and unintended pregnancy. Poisson and
logistic regression were used to assess for differences in treatment
arms.
Results: Two hundred and forty-two of 272 participants
completed the study yielding a follow-up rate of 89%. Average age
was 21 years; with 65% female; 37% White; 34% Black; 10% Asian;
7% Hispanic; and 2% Native American. At the baseline visit 75%
(99/130) reported the computer intervention was Very or
Extremely Helpful. Statistical models were adjusted for baseline
differences of self-reportedhistoryof STI and ever transactional sex.
At 3-month follow-up the Intervention group reported 33% lower
rate of unprotected vaginal sex (without condoms) [IRR¼ 0.67, 95%
CI: 0.44-1.01]; 20% fewer partners [IRR ¼ 0.80, 95% CI: 0.61-1.05];
and 48% fewer STI infections [IRR ¼ 0.52, 95% CI: 0.24-1.13]. Inter-
vention females reported lower rate of unprotected vaginal sex
(without other contraception) [IRR ¼ 0.78, 95% CI: 0.46-1.32] and
half asmanyunintendedpregnancies (n¼5) versusControl females
(n ¼ 10) [IRR ¼ 0.51, 95% CI: 0.16-1.6]. In a subgroup analysis,
Intervention females showed a signiﬁcant reduction in unprotected
vaginal sex (without condoms).
Conclusions: The interactive computer-based intervention for
sexual health was feasible to execute and was acceptable to the
study population. There was a trend in the effectiveness of the
intervention in reducing unprotected vaginal sex, number of
partners, incident STI and unintended pregnancy at 3-month
follow-up although results did not reach statistical signiﬁcance.
The intervention may be more effective in females than males.
Sources of Support: NICHD 5K23HD052621.
20.
URINARY CADMIUM AND THE TIMING OF MENARCHE AND
PUBERTAL DEVELOPMENT IN GIRLS
Rudy P. Rull, PhD 1, Alison J. Canchola, MS 2, Peggy Reynolds, PhD 2,
Pamela L. Horn-Ross, PhD 2.
1University of Nevada, Reno; 2Cancer Prevention Institute of
California.
Purpose: Cadmium (Cd) is a developmental toxicant and carci-
nogenicmetal. It is released into the environment during industrial
processes and mining operations and bioaccumulates in plants
grown in contaminated soil, especially tobacco and leafy green
vegetables. In the US and Europe, the onset of menarche and pu-
berty in girls has been decreasing for several decades. Exposures to
endocrine-disrupting chemicals and metals such as Cd in the
environment may impact the onset of puberty.
Few studies have examined whether Cd exposure affects the
onset of estrus in animals or puberty in humans. Findings from
published animal studies on the effects of in utero Cd exposure
suggest that low-dose Cd exposure accelerates the onset of estrus
by mimicking estrogen effects while exposure at higher doses
delayed the onset of estrus due to ovotoxicity. In the only human
study to date, urinary Cd concentrations in prepubertal girls was
